JENNIFER SEDLOCK: Open Payments
NPI 1619528502 · URBANA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,786 in 70 payments from 12 companies in 2025. Trend: 2023 $1,030 · 2024 $1,051 · 2025 $1,786
Food & beverage: $1,786
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $837 |
| Ardelyx, Inc. | 5 | $227 |
| Madrigal Pharmaceuticals | 7 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $197 |
| NeurAxis, Inc. | 1 | $67 |
| Ipsen Biopharmaceuticals, Inc | 3 | $59 |
| QOL Medical, LLC | 1 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $28 |
Products named: SKYRIZI, IBSRELA, REZDIFFRA, LINZESS, CREON, ENTYVIO, IQIRVO, GATTEX.
Industry payments across IL — which companies pay providers there.
